Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation
- PMID: 27840318
- DOI: 10.1016/j.freeradbiomed.2016.11.014
Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation
Abstract
Sestrin2 (SESN2) is an antioxidant protein that modulates cellular redox homeostasis through regeneration of peroxiredoxins. It has beneficial effects in oxidative or metabolic stress conditions as an upstream regulator of AMP-activated protein kinase (AMPK). Since hypoxia causes oxidative and metabolic stress, this study investigated the effect of SESN2 on signaling pathways altered by hypoxia in colon cancer cells. SESN2 overexpression in HEK293 cells inhibited hypoxia-inducible factor-1α (HIF-1α), which plays a crucial role in tumor growth and development in hypoxia. Moreover, infection with adenovirus-SESN2 (Ad-SESN2) decreased hypoxia or CoCl2-induced HIF-1α accumulation in colorectal cancer cells. Ad-SESN2 also reduced CoCl2-induced hypoxia response element (HRE)-luciferase activity and mRNA level of HIF-1α-driven genes. Furthermore, Ad-SESN2 infected cells showed anti-metastatic effects in serum-induced cell migration and invasion in vitro. Ad-SESN2 facilitated the ubiquitination of HIF-1α protein and increased hydroxyl-HIF-1α (OH-HIF-1α) level. In contrast, treatment with dimethyloxalylglycine (DMOG), an inhibitor of prolyl hydroxylase (PHD), reversed Ad-SESN2-induced OH-HIF-1α and subsequently suppressed HIF-1α level. The inhibitory effects of SESN2 on the serum-induced in vitro cell migration and invasion were also abrogated by DMOG treatment. Furthermore, knockdown of AMPKα reversed Ad-SESN2-mediated increase of OH-HIF-1α and inhibition of HIF-1α. Dominant-negative form of AMPK also restored the Ad-SESN2 mediated decrease in HIF-1α accumulation. Lastly, Ad-SESN2 suppressed tumor growth in a mouse xenograft model. Taken together, these results suggest that SESN2 increases degradation of HIF-1α via AMPK-PHD regulation that contributes to inhibition of in vitro and in vivo tumorigenesis.
Keywords: AMP-activated protein kinase; Colorectal cancer; Hypoxia-inducible factor-1α; Prolyl hydroxylase; Sestrin2.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Andrographolide inhibits hypoxia-induced HIF-1α-driven endothelin 1 secretion by activating Nrf2/HO-1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells.Environ Toxicol. 2017 Mar;32(3):918-930. doi: 10.1002/tox.22293. Epub 2016 Jun 14. Environ Toxicol. 2017. PMID: 27297870
-
RUNX3 inhibits hypoxia-inducible factor-1α protein stability by interacting with prolyl hydroxylases in gastric cancer cells.Oncogene. 2014 Mar 13;33(11):1458-67. doi: 10.1038/onc.2013.76. Epub 2013 Apr 1. Oncogene. 2014. PMID: 23542169
-
Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.Biol Pharm Bull. 2011;34(6):850-5. doi: 10.1248/bpb.34.850. Biol Pharm Bull. 2011. PMID: 21628883
-
Prolyl hydroxylase 2: a promising target to inhibit hypoxia-induced cellular metabolism in cancer cells.Drug Discov Today. 2018 Nov;23(11):1873-1882. doi: 10.1016/j.drudis.2018.05.016. Epub 2018 May 14. Drug Discov Today. 2018. PMID: 29772209 Review.
-
The possible mechanisms underlying the impairment of HIF-1α pathway signaling in hyperglycemia and the beneficial effects of certain therapies.Int J Med Sci. 2013 Aug 22;10(10):1412-21. doi: 10.7150/ijms.5630. eCollection 2013. Int J Med Sci. 2013. PMID: 23983604 Free PMC article. Review.
Cited by
-
Metformin attenuates white matter injury and cognitive impairment induced by chronic cerebral hypoperfusion.J Cereb Blood Flow Metab. 2023 Nov;43(2_suppl):78-94. doi: 10.1177/0271678X231175189. Epub 2023 May 12. J Cereb Blood Flow Metab. 2023. PMID: 37177813 Free PMC article.
-
Clinical application of RUBCN/SESN2 mediated inhibition of autophagy as biomarkers of diabetic kidney disease.Mol Med. 2022 Dec 7;28(1):147. doi: 10.1186/s10020-022-00580-8. Mol Med. 2022. PMID: 36476132 Free PMC article.
-
Sestrin2 as a Novel Biomarker and Therapeutic Target for Various Diseases.Oxid Med Cell Longev. 2017;2017:3296294. doi: 10.1155/2017/3296294. Epub 2017 Jun 11. Oxid Med Cell Longev. 2017. PMID: 28690762 Free PMC article. Review.
-
Sestrin2 ameliorates age-related spontaneous benign prostatic hyperplasia via activation of AMPK/mTOR dependent autophagy.Biogerontology. 2025 Jan 24;26(1):48. doi: 10.1007/s10522-025-10184-4. Biogerontology. 2025. PMID: 39853471
-
Sestrin2 as a gatekeeper of cellular homeostasis: Physiological effects for the regulation of hypoxia-related diseases.J Cell Mol Med. 2021 Jun;25(12):5341-5350. doi: 10.1111/jcmm.16540. Epub 2021 May 4. J Cell Mol Med. 2021. PMID: 33942488 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases